Skip to Main Content
Access your saved content
Information technology executives at life sciences companies are both blessed and cursed by the dynamics shaping their industry.
The potential to enter new markets and reach unserved consumers makes for exciting times. And with today’s collaboration-enhancing technology, it is easier than ever for healthcare professionals worldwide to share ideas and information and reach patients. Meanwhile, IT executives working in the sector continue to respond to the traditional demands of delivering efficient, secure IT services for their organizations, and find they must often make difficult strategic and operational trade-offs and investment choices.
In one of the toughest healthcare environments ever, with increasing expectations from consumers, regulators, providers and payers, how can life sciences IT leaders be assured they will make the right decisions? They need to advance their companies’ growth strategies, lower total cost of IT ownership and incorporate technology advances that underpin the services their internal and external stakeholders need. Is meeting these goals even possible?
Accenture’s perspective is that IT leaders can meet both strategic business and traditional delivery goals by exploiting five trends:
Like most enterprise functions, IT plays a dual role: It has very real, internal, daily operational imperatives to meet while also supporting evolving business strategies. The pace of technological innovation makes it difficult to assess which investments make sense to perform each role responsibly. Traditional concerns, from managing total cost of ownership to attracting and retaining IT talent, and finding solutions to these challenges, will continue to command CIO attention. However, these issues, while important, should not prevent a CIO from tracking and harvesting technology trends that could enable company growth and differentiation.
CIOs are understandably intrigued by— and skeptical of— new technology trends; however, Accenture believes that the five trends described here deserve serious consideration. Most life sciences companies will be hard-pressed to understand and serve potential consumers and providers in emerging markets without leveraging all of these trends. Nor could companies.
February 4, 2011
Skip Footer Links